Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-01-04
2011-01-04
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S111000, C536S123120
Reexamination Certificate
active
07863260
ABSTRACT:
Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases.
REFERENCES:
patent: 4775638 (1988-10-01), Haisma
patent: 5218108 (1993-06-01), Sommermeyer et al.
patent: 5502043 (1996-03-01), Weidler et al.
patent: 6083909 (2000-07-01), Sommermeyer et al.
patent: 6610294 (2003-08-01), Lederman et al.
patent: 6680305 (2004-01-01), Segall et al.
patent: 7285661 (2007-10-01), Sommermeyer et al.
patent: 0170275 (1986-02-01), None
patent: 0402724 (1990-12-01), None
patent: 1395777 (1975-05-01), None
patent: WO 00/48637 (2000-08-01), None
patent: WO03/070772 (2003-08-01), None
“STN Database Descriptions” from 2006 Chemical Abstracts Catalog, published 2006 by Chemical Abstracts Service, p. 52.
Felfenig et al., “The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients” Acta Anaesthesiol Scand (2003) vol. 47 pp. 70-73.
Deusch, “The Effects of High Molecular Weight Hydroxyethyl Starch Solutions on Platelets” Anesthesia and Analgesia (2004) vol. 99, pp. 665-668.
Jaeger et al., “Effects of colloidal resuscitation fluids on the neutrophil respiratory burst” Transfusion (2001) vol. 41 pp. 1064-1068.
Madjpour et al., “Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?” British Journal of Anaesthesia (2005) vol. 94 No. 5, pp. 569-576.
De Belder, et al. “The Substitution Patterns of 0-(2-Hydroxyethyl)Starch and 0-(2-Hydroxyethyl)Dextran” Carbohydrate Research, XP002329873 Amsterdam das ganze Dokument, vol. 10, 1969, pp. 391-394.
Boll Michael
Fisch Andreas
Spahn Donat R.
B. Braun Melsungen AG
Klein O'Neill & Singh, LLP
Olson Eric S
LandOfFree
Hydroxyethylstarch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxyethylstarch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyethylstarch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663077